BIOSYNTH Carbosynth Logo (WIPO, 06/16/2020)
WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark BIOSYNTH Carbosynth was filed as Figurative mark on 06/16/2020 at the World Intellectual Property Organization.
Logodesign (Wiener Klassifikation)
#Quadrilaterals #Letters presenting a special form of writing #Colours
| Trademark form | Figurative mark |
| File reference | 1553343A |
| Countries | 
|
| Application date | June 16, 2020 |
| Expiration date | June 16, 2030 |
Trademark owner
Schorndorfer Strasse 32
70734 Fellbach
DE
70734 Fellbach
DE
Trademark representatives
Dentons US LLP,
P.O. Box 1302
US
goods and services
01
Biochemicals and organic chemicals used as enzyme
substrates, enzyme inducers, namely, aminoglutethimides,
carbamazepines, griseofulvins, and primidones, enzyme
inactivators, or cultural medium additives for use in the
field of microbiology and molecular biology; biochemical and
organic chemicals for use in the manufacture of
pharmaceuticals and cosmetics; chemical reagents for medical
research use in the field of immunology
05
Medicinal preparations, namely, photosensitizing agents used
as a dermatologic drug for the treatment of skin cancer by
phototherapy; chemical reagents for medical or veterinarian
use; chemical reagents for use as a culture media for
cultures of microorganisms for medical use, namely, for the
isolation and identification of the bacteria strain
Escherichia coli O157:H7; chemical preparations for medical
purposes, namely, for Cholesterol testing to prevent
possible consequences of Hypercholesterolemia such as
atherosclerosis, coronary heart disease and other forms of
cardiovascular diseases; chemical preparations for medical
purposes, namely, for novel enzyme responsive inhibitors
that allow for modifications of the composition of microbial
communities; organic chemical preparations for medical
purposes, namely, immunomodulators with anti-inflammatory
properties; organic chemical preparations and enzymes for
medical laboratory analysis purposes, namely, for medical
detection, identification and quantification of strains of
pathogenic bacteria; chemical preparations for medical
laboratory analysis purposes, namely, for medical
immunological and microbiological blood testing; chemical
preparations for medical laboratory analysis purposes,
namely, for medical detection of pathogenic bacteria,
namely, various strains of Listeria, Clostridium, Bacillus
and Staphylococcus; chemical preparations for medical
laboratory analysis purposes, namely, for the medical
detection and quantification of bacteria strains of
Escherichia coli; medical preparations for the diagnosis of
Staphylococus aureus, in particular for
Methicillin-resistant Staphylococcus aureus (MRSA);
biochemical and organic chemical reagents for clinical
diagnostic laboratory use; chemical reagents for medical
laboratory analysis purposes, namely, for use as a routine
medical supplement to blood culture media in vitro to
inhibit blood coagulation and to improve the detection
limits for individual microorganisms
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| November 22, 2022 | 2022/47 Gaz | KR | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| October 26, 2021 | 2021/43 Gaz | KR | Rejection |
ID: 999914155334365